Amgen discloses cloud breach affecting company and patient data
Amgen reported data exfiltration from third-party-hosted cloud environments, including potential patient PHI. We analyse shared responsibility and response.
- AUTHOR
- Karol Rapacz / CEO of Breachroad · OSCP · PNPT
- PUBLISHED
- 1 August 2026
- READING TIME
- 12 min read
- TOPIC
- Threats and Incidents
Amgen has disclosed unauthorised activity in cloud environments hosted by a third-party provider in a filing with the US Securities and Exchange Commission. An attacker exfiltrated proprietary company data, patient protected health information — PHI — and other information.
The company has not publicly named the provider, initial access vector, number of affected people or actor. The investigation remains active, so a responsible analysis must separate confirmed scope from speculation. The case already provides useful lessons about shared responsibility, logging and the time needed to detect exfiltration in environments holding sensitive data.
What Amgen reported
In its Form 8-K filed with the SEC, Amgen says it:
- identified unauthorised activity in third-party-hosted cloud environments in July;
- activated incident-response procedures and engaged external experts;
- notified law enforcement;
- determined that proprietary company data, patient PHI and other information had been exfiltrated;
- continues to assess the nature and scope of the data;
- determined on 29 July that the incident was material.
The company has identified no impact on product delivery, manufacturing operations, financial reporting or its ability to serve patients’ needs. That does not mean individuals whose data may have been disclosed face no harm.
What remains unknown
The public filing does not yet answer key questions:
- whether the compromised identity belonged to a user, workload or administrator;
- whether entry involved misconfiguration, a vulnerability, API key, session token or supplier;
- how long access persisted;
- which PHI and company-data elements were copied;
- how many patients, employees or partners are affected;
- whether data was encrypted and whether keys were accessible;
- whether the attacker maintained access elsewhere.
This uncertainty is not a basis for naming a particular group. Actor claims in unofficial channels should remain unverified unless Amgen, law enforcement or a credible technical report provides evidence.
Why “hosted by a provider” remains a customer responsibility
Cloud services divide duties; they do not eliminate them. A provider may secure physical data centres and the service layer while the customer still controls:
- human and workload identities;
- roles and access policies;
- storage and sharing configuration;
- keys, secrets and integrations;
- data classification;
- log retention and export;
- detection of unusual use;
- response processes and legal obligations.
In SaaS, more of these elements may sit with the service operator, but customers still need to know which logs they will receive, how quickly the provider will preserve artifacts and who can revoke sessions. A contract does not substitute for technical investigative capability.
Exfiltration is a data problem, not only an account problem
If an attacker downloaded files or records, closing a session removes access but cannot restore confidentiality. Responders need to determine:
- which repositories were visible to the compromised identity;
- which objects were read or exported;
- whether the data contained identifying, clinical, contact or payment information;
- whether files included secrets leading to other systems;
- which notification duties the actual scope triggers.
PHI is not one uniform category. A name and the fact of a relationship with a healthcare organisation have a different impact from a complete treatment history, but either can support targeted phishing, insurance fraud or coercion.
The first response hours
An organisation facing a similar event should separate continuity protection from evidence preservation:
- constrain the affected identity and revoke active sessions;
- snapshot configuration, IAM policy and logs before broad changes;
- preserve audit logs in an independent account or tenant;
- rotate secrets readable from the affected environment;
- inspect new keys, roles, sharing rules and persistence mechanisms;
- monitor every integration using the same data;
- put legal, privacy, security and communications teams on one timeline.
“Switch everything off” may interrupt some activity, but it can also destroy volatile evidence and harm patients or operations. Decisions require an accountable risk owner and good telemetry.
Detecting bulk access
Not every exfiltration appears as one enormous transfer from one system. An attacker can retrieve data in batches, use a legitimate API, abuse an administrative export or operate through a synchronisation tool.
Detection should cover:
- sudden growth in read and list operations;
- exports outside the normal business window;
- new regions, network addresses and unusual user agents;
- one token used from multiple locations within an implausible interval;
- creation of public links or changes to access policy;
- data copied into a new account, bucket or application;
- administrative calls immediately preceding large reads;
- unusual queries against PHI datasets.
Baselines need to distinguish automated business processes from human activity. An alert saying “one million records were downloaded” becomes useful only when the system knows whether a legitimate pipeline does that every day.
Architecture that limits blast radius
Minimum access to specific datasets matters more than a general belief that an environment is private. Useful controls include:
- separate identities for each integration and workload;
- short-lived credentials instead of static keys;
- data segmentation by purpose and sensitivity;
- an independent audit trail outside the production account;
- egress and export controls;
- encryption keys with monitored use;
- DLP that understands clinical context;
- regular tests of access revocation and log recovery.
Encryption at rest protects against some infrastructure scenarios. It does not protect against a legitimately authenticated application or user for whom the service decrypts data during a read. IAM and telemetry therefore matter as much as the encryption algorithm.
Communicating with affected people
A notice should state what is known, what remains under investigation and which actions are genuinely useful. Generic advice to “change your password” may be insufficient where health information that cannot be changed is involved.
Organisations should prepare:
- a trustworthy channel for validating the notice;
- dedicated support that does not request more sensitive data;
- a warning about phishing tailored to treatment context;
- a clear description and duration of any protection offered;
- updates when the investigation changes the assessment.
Primary facts versus Breachroad analysis
Amgen confirms unauthorised activity, third-party-hosted cloud environments, exfiltration of company data and PHI, an ongoing investigation and no identified effect on production, reporting or product delivery.
Breachroad does not attribute the event to a particular actor or estimate an affected population without source data. Our conclusion is that logging and restrictions must be designed before an incident: after exfiltration, an organisation can answer only the questions for which it retained independent evidence.
Organisational cybersecurity training helps technical, legal and business teams rehearse a coordinated response. A cloud security assessment can evaluate IAM, logging, storage, encryption, DLP and supplier readiness.


